Device Trial Radar · NCT06109051
EndeavorOTC™ Prospective Product Registry
Last checked: Nov 20, 2026Latest source record: Jun 27, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
198
Actual
Start
Oct 3, 2023
Primary completion
Dec 31, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Akili Interactive Labs, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 31, 2023
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes
Summary
As written by the sponsor on the registry.
The EndeavorOTC product registry aims to collect real world data from EndeavorOTC users. The objectives of this registry are to describe clinical and demographic characteristics, treatment patterns, clinical and quality of life outcomes, and healthcare utilization in EndeavorOTC users in a real-world setting.
Conditions
- ADHD
Interventions
EndeavorOTCDevice
EndeavorOTC™ is an over-the-counter digital therapeutic designed to improve attention function, ADHD symptoms, and quality of life in users 18 years of age and older with primarily inattentive or combined-type ADHD, who have been identified as having a significant attentional impairment. EndeavorOTC utilizes the same proprietary technology underlying EndeavorRx, a prescription digital therapeutic indicated to improve attention function in children ages 8-12. EndeavorOTC is not intended to be a replacement for any form of ongoing treatment. EndeavorOTC is deployed on mobile devices and incorporates adaptive, simultaneous cognitive tasks in a consumer-grade action videogame-based platform with high-quality graphics and reward mechanisms.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Computerized Adaptive Test, Mental Health (CAT-MH®)Time frame: Baseline, Months 1, 2, 3, 6, 9, 12
- Conners' Adult ADHD Rating Scales-Self Report: Short Version (CAARS-S:S)Time frame: Baseline, Months 1, 2, 3, 6, 9, 12
- Adult ADHD Quality of Life (AAQoL)Time frame: Baseline, Months 1, 2, 3, 6, 9, 12
8 more outcomes with a free account
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Akili Interactive Labs, Inc.
Boston, Massachusetts
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.